Achondroplasia Treatment Market is Estimated To Witness High Growth Owing To Escalating Demand For Personalized And Targeted Therapies

Market Overview: Achondroplasia is the most common form of dwarfism. It is caused by a mutation in the FGFR3 gene which responsible for regulating bone growth. Current treatment options are limited and focus on symptomatic relief through orthopedic surgeries. The development of targeted and personalized therapies offers hope to patients by addressing the underlying cause … Read more

Achondroplasia Treatment Market Estimated To Witness High Growth Owing To Rising Prevalence And Advancements in Treatment Options

The Achondroplasia Treatment Market is estimated to be valued at US$ 127.8 million in 2023 and is expected to exhibit a CAGR of 36.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.